Pre-submission services

Streamline Your Market Entry with Expert Pre-Submission Support
Navigating Post Submission Challenges with Seamless Transition from Submission to Approval

We navigate regulatory pathways for successful market entry by our pre-submission services

We provides complete pre-submission services to help pharmaceutical manufacturers navigate the regulatory landscape and optimize their submissions for regulatory approval, ensuring a successful outcome for pharmaceutical, biologic, medical device, or in-vitro diagnostic products.
Engaging in pre-submission discussions such as FDA and other regulatory bodies is a crucial step in drug’s development, approval, commercialization, and medical device regulation. Pharmaceutical company should utilize this opportunity to present their products and regulatory plans to the FDA and health authorities, seeking their advice on the best course of action.

After reviewing an application, health authorities (HAs) may contact a sponsor or Marketing Authorization Holder (MAH) if the evidence is insufficient or further information is needed regarding efficacy, safety, and quality. This interaction underscores the proactive engagement with regulatory authorities.

Zenovel serves as a global regulatory partner for pharmaceutical companies, managing regulatory agency interactions and health authority meetings for drug development, approval, and post-approval changes. With a robust regulatory team of industry professionals and ex-agency experts, we support sponsors during agency meetings and ensure successful regulatory approval outcomes.
Reduce delays, and increase their chances of approval.
Enhance communication and collaboration between clients and regulatory authorities, promoting transparency, trust, and alignment throughout the submission process.
We help clients ensure your regulatory submissions meet all necessary standards and expectations, reducing the risk of non-compliance.
Tailoring regulatory strategies, navigating regulatory pathways, optimizing resource allocation, and enhancing efficiency of regulatory submission
Reach out to us for any inquiries or support needs.

Blogs and news

Our Latest Article